2025 Europe Automated Cannabis Testing Market Revenue Opportunities Report
Description
The 2025 Europe Automated Cannabis Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automated Cannabis Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the automated cannabis testing market in Europe are Agilent Technologies Inc., PerkinElmer Inc., Medicinal Genomics Corp., and Hamilton Company. These companies are key global players that also have significant operations and market penetration in Europe, driven by increasing legalization, growing demand for medicinal cannabis, and regulatory requirements for quality and safety testing. Agilent Technologies provides advanced analytical instruments such as HPLC systems for cannabinoid profiling, enabling compliance with stringent European regulatory standards. PerkinElmer and Hamilton Company focus on delivering automated analyzers and robotics to boost throughput and precision in cannabis testing labs, while Medicinal Genomics Corp. specializes in genetic and molecular diagnostic solutions for cannabis quality assurance.
Europe's automated cannabis testing market is expanding rapidly, particularly in countries like Germany and Malta, due to regulatory approvals, a rise in testing laboratories adopting lab automation, and increasing demand for high-quality medicinal cannabis products. These companies invest in product innovation and strategic partnerships to capture the growing European market, which is projected to grow at a CAGR of around 11.5–17.8% through the next decade. The adoption of chromatography and spectroscopy-based analyzers for cannabinoid and contaminant profiling is particularly strong in the region, supporting robust growth and technological advancements led by these four companies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automated Cannabis Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the automated cannabis testing market in Europe are Agilent Technologies Inc., PerkinElmer Inc., Medicinal Genomics Corp., and Hamilton Company. These companies are key global players that also have significant operations and market penetration in Europe, driven by increasing legalization, growing demand for medicinal cannabis, and regulatory requirements for quality and safety testing. Agilent Technologies provides advanced analytical instruments such as HPLC systems for cannabinoid profiling, enabling compliance with stringent European regulatory standards. PerkinElmer and Hamilton Company focus on delivering automated analyzers and robotics to boost throughput and precision in cannabis testing labs, while Medicinal Genomics Corp. specializes in genetic and molecular diagnostic solutions for cannabis quality assurance.
Europe's automated cannabis testing market is expanding rapidly, particularly in countries like Germany and Malta, due to regulatory approvals, a rise in testing laboratories adopting lab automation, and increasing demand for high-quality medicinal cannabis products. These companies invest in product innovation and strategic partnerships to capture the growing European market, which is projected to grow at a CAGR of around 11.5–17.8% through the next decade. The adoption of chromatography and spectroscopy-based analyzers for cannabinoid and contaminant profiling is particularly strong in the region, supporting robust growth and technological advancements led by these four companies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
